STAT July 23, 2024
When Sanjaya Singh left Johnson & Johnson in 2021, his former colleague Peter Lebowitz paid close attention.
Singh had been a mainstay in the immunology and oncology fields, helping to invent the blockbuster drug Skyrizi and several other treatments during stints at Johnson & Johnson and Boehringer Ingelheim. “If Sanjaya Singh is doing...